What is Generate Biomedicines, Inc. 's current ratio?

Generate Biomedicines, Inc. (GENB) reported current ratio of 9.2× in Q1 2026.

What does current ratio mean?

Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.

Generate Biomedicines, Inc. GENB Current ratio

Current ratio at other companies

RepligenRGEN

9.2×+2.4×

MYR GroupMYRG

1.3×0.0×

Boyd GamingBYD

0.6×-0.2×

LKQLKQ

1.5×0.0×

CHE

ChemedCHE

0.9×-0.9×

Sensata TechnologiesST

2.8×+0.1×

Other financials

Income statement

See full

Revenue$7.2M-18.1%

Operating income-$64.1M-33.1%

Net income-$61.4M-47.4%

EPS (diluted)-$1.07+34.0%

Balance sheet

See full

Cash & equivalents$160.6M-27.2%

Total debt$65.6M—

Total equity$514.8M+209%

Total assets$625.7M—

Cash flow

See full

Operating cash flow-$80.4M-51.2%

CapEx$3.8M+403%

Free cash flow-$84.2M-56.1%

Valuation

See full

Market cap$1.86B—

Enterprise value$1.76B—

Returns & leverage

See full

Debt / equity0.1×—

Where this comes from

Calculated from Generate Biomedicines, Inc. ’s reported figures.

total current assets/total current liabilities=9.2×

Based on the most recent quarter.

The official record: Generate Biomedicines, Inc. ’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Generate Biomedicines, Inc. 's current ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Generate Biomedicines, Inc. 's current ratio?: Generate Biomedicines, Inc. (GENB) reported current ratio of 9.2× in Q1 2026.
What does current ratio mean?: Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.